SCHEMBL5367001

SCHEMBL5367001

COc1ccc(Cc2ccc(=O)[nH]n2)cc1C(=O)c1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
CYP3A4 P08684 1/20 0.42
ALDH1A1 P00352 4/20 0.41
POLB P06746 1/20 0.41
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CTNNB1 P35222 1/20 0.40
WNT3A P56704 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373711 0.78 CYP3A4 (0.49) MAPTHTTSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL5371246 0.78 CYP3A4 (0.48) NPSR1CYP3A4ALDH1A1NPC1MEN1
SCHEMBL8526363 0.76 MAPT (0.44) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL7582450 0.76 PDE4A (0.38) HTTSMN1; SMN2CYP3A4ALDH1A1POLB
SCHEMBL7590521 0.75 HPGD (0.48) MAPTCYP3A4ALDH1A1L3MBTL1LMNA
SCHEMBL7583504 0.74 ALDH1A1 (0.40) MAPTHTTSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL7584819 0.74 ADRB2 (0.39) MAPTSMN1; SMN2CYP3A4ALDH1A1POLB
SCHEMBL5377330 0.74 CYP3A4 (0.52) CYP3A4NPC1MEN1RAB9AKMT2A
SCHEMBL5370322 0.73 CYP3A4 (0.53) MAPTNPSR1SMN1; SMN2CYP3A4ALDH1A1
SCHEMBL30785051 0.72 MAPT (0.69) MAPTHTTNPSR1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
EP-0810218-B1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) HOFFMANN LA ROCHE (CH) 2002-12-04 EP disclosed
EP-0810218-A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) F. HOFFMANN-LA ROCHE AG (CH) 1997-12-03 EP disclosed